Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).
View/ Open
Date
2019-04-01Author
Messiou, C
Hillengass, J
Delorme, S
Lecouvet, FE
Moulopoulos, LA
Collins, DJ
Blackledge, MD
Abildgaard, N
Østergaard, B
Schlemmer, H-P
Landgren, O
Asmussen, JT
Kaiser, MF
Padhani, A
Type
Journal Article
Metadata
Show full item recordAbstract
Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and hematologists with specific expertise in whole-body MRI in myeloma convened to discuss the technical performance standards, merits, and limitations of currently available imaging methods. Following guidance from the International Myeloma Working Group and the National Institute for Clinical Excellence in the United Kingdom, the Myeloma Response Assessment and Diagnosis System (or MY-RADS) imaging recommendations are designed to promote standardization and diminish variations in the acquisition, interpretation, and reporting of whole-body MRI in myeloma and allow response assessment. This consensus proposes a core clinical protocol for whole-body MRI and an extended protocol for advanced assessments. Published under a CC BY 4.0 license. Online supplemental material is available for this article.
Collections
Subject
Humans
Multiple Myeloma
Magnetic Resonance Imaging
Data Collection
Consensus
Research Design
Whole Body Imaging
Practice Guidelines as Topic
Research team
Myeloma Group
Computational Imaging
Language
eng
License start date
2019-04
Citation
Radiology, 2019, 291 (1), pp. 5 - 13
Publisher
RADIOLOGICAL SOC NORTH AMERICA